FDA Reduces Advisory Meetings Amid Controversial Decisions
The FDA is cutting back on public advisory committee meetings as contested drug approval decisions mount, raising transparency concerns for patients nationwide.
By Priya Patel
advisory committees
2 articles tagged "advisory committees"
FDA Advisory Committees Decline & Biosimilar Rule Changes
FDA faces scrutiny over a 63% drop in advisory committee meetings in 2025 and new moves to ease biosimilar development requirements in 2026.